SynBioBeta Speaker
Monique Coy
Corteva Agriscience
Program Leader
Monique Coy, Ph.D., is a biotechnology strategist and systems-oriented program leader working at the intersection of plant science and innovation design. Her work focuses on building the frameworks and platforms that enable discovery, from regulatory element strategy to scalable molecular infrastructure.She has led efforts to expand transformation capacity, design experimental systems, and structure the iteration cycles that connect design, experimentation, and learning. She also evaluates emerging DNA synthesis and automation technologies, with a focus on how these capabilities can reshape construct design and accelerate future R&D pipelines.She is particularly interested in how well-designed systems can unlock new directions in agricultural biotechnology.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Monique
This Year
•
-
Tools & Tech
Breaking the Barriers of DNA Synthesis: Shattering the Ceiling?
For decades, DNA synthesis has been the limiting reagent in synthetic biology — reliable for short sequences, but increasingly error-prone and costly as designs scale. That ceiling is now cracking. New enzymatic synthesis platforms, error-correction chemistries, and assembly pipelines are extending what’s possible, opening the door to rapid construction of full pathways, microbial genomes, and even mammalian chromosomes. This session will explore how innovators are breaking past barriers, what technical and economic breakthroughs are needed next, and how longer, cheaper, and faster synthesis could fundamentally change how we design biology at scale.
Featuring
Jason Gammack
Ansa Biotechnologies
CEO
Turning DNA synthesis into a predictable, on-time “reagent.”
Emily Leproust
Twist Bioscience
CEO
Leader in DNA Manufacturing, put DNA writing on silicon.
Monique Coy
Corteva Agriscience
Program Leader
Jodi Barrientos
Ribbon Bio
CEO
Andrew Han
GenomeWeb
Editor
GenomeWeb editor covering sequencing and diagnostics markets.
•
-
Tools & Tech
Breaking the Barriers of DNA Synthesis: Shattering the Ceiling?
For decades, DNA synthesis has been the limiting reagent in synthetic biology — reliable for short sequences, but increasingly error-prone and costly as designs scale. That ceiling is now cracking. New enzymatic synthesis platforms, error-correction chemistries, and assembly pipelines are extending what’s possible, opening the door to rapid construction of full pathways, microbial genomes, and even mammalian chromosomes. This session will explore how innovators are breaking past barriers, what technical and economic breakthroughs are needed next, and how longer, cheaper, and faster synthesis could fundamentally change how we design biology at scale.
Featuring
Jason Gammack
Ansa Biotechnologies
CEO
Turning DNA synthesis into a predictable, on-time “reagent.”
Emily Leproust
Twist Bioscience
CEO
Leader in DNA Manufacturing, put DNA writing on silicon.
Monique Coy
Corteva Agriscience
Program Leader
Jodi Barrientos
Ribbon Bio
CEO
Andrew Han
GenomeWeb
Editor
GenomeWeb editor covering sequencing and diagnostics markets.
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
